Science Market Update

Stony Brook Lyme Disease Vaccine Shows Promise in Clinical Trials

Posted by Jennifer Nieuwkerk on Mon, Aug 26, 2013

Clinical trials were recently conducted and proved promising for a Lyme Disease vaccine developed by science researchers at Stony Brook University. The vaccine proved to produce a large number of antibodies against all targeted species of Borrelia, which causes Lyme Disease in Europe and the United States. Baxter International S.A., who worked with Stony Brook University researchers to develop the vaccine, conducted the clinical trials.

Read More

Tags: 2014, 2013, Northeast, Lyme Disease, vaccine, New York, Stony Brook University, BioResearch Product Faire Event, NY, Stony Brook, research news, SunySB

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!